Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01856946 · ClinicalTrials.gov registry record · NA
Effect of Vitamin D Supplementation on Oral Glucose Tolerance Among Obese Adolescents
A NA study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
NCT01856946 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 15 participants.
The verdict
NCT01856946, a NA study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
Study Summary
Childhood obesity is a rapidly growing epidemic in the US and the world. Current estimates suggest that 30% of our nation's children are either overweight ot obese. Obesity is a major risk factor towards the development of insulin resistance, which, in turn is a major risk factor for the development of type 2 diabetes. Prior research has suggested that vitamin D therapy may be a safe, inexpensive, and effective method of reducing insulin resistance and a person's risk of developing diabetes. The investigators' prior studies have shown that daily 4,000 IU vitamin D therapy is a safe and effective method of improving insulin resistance based on a calculation called the HOMA-IR. The next step in identifying whether vitamin D truly improves insulin resistance is to use oral glucose tolerance testing (OGTT), which is a better real-life measure of insulin resistance compared to the previously used HOMA-IR.
Interventions
- DIETARY_SUPPLEMENT 4,000 IU vitamin D3
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2013-05 |
| Est. Completion | 2014-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01856946
The ClinicalTrials.gov registry entry for NCT01856946 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 4,000 IU vitamin D3 is the first listed.
NCT01856946 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01856946 about?
NCT01856946 is a clinical study titled "Effect of Vitamin D Supplementation on Oral Glucose Tolerance Among Obese Adolescents". Childhood obesity is a rapidly growing epidemic in the US and the world. Current estimates suggest that 30% of our nation's children are either overweight ot obese. Obesity is a major risk factor towards the development of insulin resistance, which, in turn is a major risk factor for the development...
What is the current status of trial NCT01856946?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2013-05. Estimated completion is 2014-02.
What interventions are being tested in trial NCT01856946?
The interventions under investigation include: 4,000 IU vitamin D3 (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01856946?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.